These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10579746)

  • 1. Angiotensin II receptor antagonists: enlarging therapeutic possibilities in arterial hypertension.
    Plante GE
    Can J Cardiol; 1999 Nov; 15 Suppl F():4F-6F. PubMed ID: 10579746
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X.
    Feldman R
    Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
    MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can Sartane help a failing heart? AT1-receptor antagonists in cardiac insufficiency].
    Düsing R
    Pharm Unserer Zeit; 2001; 30(4):314-20. PubMed ID: 11499257
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R; Bonhomme MC; Diebold S
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
    Dominiak P; Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists: what future?
    Onuigbo M
    South Med J; 1998 Aug; 91(8):794-6. PubMed ID: 9715233
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on the efficacy of angiotensin receptor blockers in treatment of hypertension.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S386-91. PubMed ID: 16300453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application to the internist practice. The place of AT1 receptor antagonists].
    Dusleag H
    Pharm Unserer Zeit; 2001; 30(4):322-5. PubMed ID: 11499258
    [No Abstract]   [Full Text] [Related]  

  • 11. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension.
    Park JB; Intengan HD; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):40-5. PubMed ID: 11967798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

  • 14. [What are the consequences of the LIFE Study for general practice].
    Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):48. PubMed ID: 12395704
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system and cardiovascular disease.
    Hollenberg NK
    Blood Press Suppl; 2000; 1():5-8. PubMed ID: 11059628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recommendations regarding AT1 receptor antagonists. Selection criteria of the drug commission].
    Kämmerer W; Sigmund M
    Pharm Unserer Zeit; 2001; 30(4):327-30. PubMed ID: 11499259
    [No Abstract]   [Full Text] [Related]  

  • 19. AT(1)-receptor blockers: differences that matter.
    Gradman AH
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S9-S16. PubMed ID: 12140723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effect of angiotensin II receptor antagonists.
    White M
    Can J Cardiol; 1999 Nov; 15 Suppl F():10F-4F. PubMed ID: 10579747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.